| |
| |
|
| Insider
Information: |
Kapoor John N |
| Relationship: |
10% Owner |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
3,900,456 |
|
|
Indirect Shares
|
35,715,585 |
|
|
| Direct
Value |
$15,117 |
|
|
|
Indirect Value
|
$832,493 |
|
|
| Total
Shares |
39,616,041 |
|
|
| Total
Value |
$847,610 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cordex Pharma Inc |
CDXP |
Director, 10% Owner |
|
0 |
2004-08-30 |
1,408,049 |
Premium* |
|
|
Electric Motors Corporation |
EMCO |
Director |
2005-02-24 |
0 |
2006-07-31 |
3,305,173 |
Premium* |
|
|
Introgen Therapeutics Inc |
INGNQ |
Director |
2007-05-30 |
3,354,995 |
2005-04-11 |
0 |
Premium* |
|
|
Akorn Inc |
AKRX |
Director, 10% Owner |
2017-05-04 |
513,479 |
2017-05-04 |
30,946,075 |
Premium* |
|
|
Insys Therapeutics, Inc. |
INSY |
10% Owner |
2017-08-11 |
31,982 |
2018-02-27 |
56,288 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRX |
Akorn Inc |
Director, 10% owner |
– – – |
2012-03-16 |
144 |
NP |
$0.00 |
$6,000,000 |
/ |
500,000 |
0 |
|
- |
|
| AKRX |
Akorn Inc |
Director, 10% owner |
– – – |
2012-03-16 |
144 |
NP |
$0.00 |
$12,000,000 |
/ |
1,000,000 |
0 |
|
- |
|
| AKRX |
Akorn Inc |
Director, 10% owner |
– – – |
2012-03-16 |
144 |
NP |
$0.00 |
$6,000,000 |
/ |
500,000 |
0 |
|
- |
|
| AKRX |
Akorn Inc |
Director, 10% Owner |
– – – |
2012-12-06 |
144 |
NP |
$0.00 |
$4,861,529 |
/ |
372,531 |
0 |
|
- |
|
| AKRX |
Akorn Inc |
Director, 10% Owner |
– – – |
2012-12-06 |
144 |
NP |
$0.00 |
$4,284,093 |
/ |
328,283 |
0 |
|
- |
|
| AKRX |
Akorn Inc |
Director, 10% Owner |
– – – |
2012-12-06 |
144 |
NP |
$0.00 |
$978,750 |
/ |
75,000 |
0 |
|
- |
|
| AKRX |
Akorn Inc |
Director, 10% Owner |
– – – |
2012-12-06 |
144 |
NP |
$0.00 |
$2,421,297 |
/ |
185,540 |
0 |
|
- |
|
| AKRX |
Akorn Inc |
Director, 10% Owner |
– – – |
2012-12-06 |
144 |
NP |
$0.00 |
$11,133,033 |
/ |
853,106 |
0 |
|
- |
|
| AKRX |
Akorn Inc |
Director, 10% Owner |
– – – |
2012-12-06 |
144 |
NP |
$0.00 |
$2,421,297 |
/ |
185,540 |
0 |
|
- |
|
| AKRX |
Akorn Inc |
Director, 10% owner |
– – – |
2014-08-27 |
144 |
NP |
$0.00 |
$1,951,000 |
/ |
50,000 |
0 |
|
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • • |
2014-05-19 |
4 |
OE |
$7.26 |
$148,482 |
D/D |
15,991 |
15,991 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
10% Owner |
– – • |
2018-02-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(42,536,080) |
56,288 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • • |
2006-03-17 |
4 |
D |
$4.62 |
$1,124,998 |
D/D |
(243,506) |
402,518 |
|
- |
|
| AKRX |
Akorn Inc |
Director |
– • • |
2012-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
496,173 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • • |
2013-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,557 |
500,730 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • • |
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,088 |
513,479 |
0 |
- |
|
| AKRX |
Akorn Inc |
Director |
– • • |
2006-03-17 |
4 |
OE |
$2.25 |
$1,125,000 |
D/D |
500,000 |
646,024 |
|
- |
|
| CDXP |
Cordex Pharma Inc |
Director |
– • • |
2004-08-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,408,049 |
|
- |
|
| EMCO |
Electric Motors Corporati... |
Director |
– • – |
2006-07-31 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,263,878 |
3,305,173 |
|
- |
|
| INGNQ |
Introgen Therapeutics Inc |
Director |
– • • |
2005-04-11 |
4 |
OE |
$0.39 |
$15,014 |
D/D |
38,400 |
3,339,576 |
|
- |
|
| INGNQ |
Introgen Therapeutics Inc |
Director |
– • – |
2006-05-23 |
4 |
A |
$0.00 |
$8 |
D/D |
7,500 |
3,347,076 |
|
- |
|
| INGNQ |
Introgen Therapeutics Inc |
Director |
– • – |
2007-05-30 |
4 |
A |
$0.00 |
$8 |
D/D |
7,919 |
3,354,995 |
0 |
- |
|
| EMCO |
Electric Motors Corporati... |
Director |
– • • |
2005-02-24 |
4 |
S |
$19.50 |
$16,770,000 |
I/I |
(860,000) |
6,379,368 |
|
- |
|
| EMCO |
Electric Motors Corporati... |
Director |
– • • |
2005-08-23 |
4 |
S |
$13.45 |
$6,725,000 |
I/I |
(500,000) |
7,569,051 |
|
- |
|
| EMCO |
Electric Motors Corporati... |
Director |
– • • |
2005-08-22 |
4 |
S |
$13.12 |
$6,560,000 |
I/I |
(500,000) |
8,069,051 |
|
- |
|
58 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
